Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Experimental and Therapeutic Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-0981 Online ISSN: 1792-1015
Journal Cover
January-2020 Volume 19 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
January-2020 Volume 19 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

miRNA‑429 suppresses osteogenic differentiation of human adipose‑derived mesenchymal stem cells under oxidative stress via targeting SCD‑1

Retraction in: /10.3892/etm.2022.11311
  • Authors:
    • Changgong Lan
    • Lizhen Long
    • Kegong Xie
    • Jia Liu
    • Landao Zhou
    • Shengcai Pan
    • Junqing Liang
    • Zhenyang Tu
    • Ziran Gao
    • Yujin Tang
  • View Affiliations / Copyright

    Affiliations: The First Affiliated Hospital of Jinan University, Guangzhou, Guangdong 510630, P.R. China, Affiliated Hospital of Youjiang Medical College for Nationalities, Baise, Guangxi 533000, P.R. China
    Copyright: © Lan et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Pages: 696-702
    |
    Published online on: November 26, 2019
       https://doi.org/10.3892/etm.2019.8246
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Role of microRNA‑429 (miRNA‑429) in osteogenic differentiation of hADMSCs was elucidated to explore the potential mechanism. Serum level of miRNA‑429 in osteoporosis patients and controls was determined by quantitative real‑time polymerase chain reaction (qRT‑PCR). After H2O2 induction in hADMSCs, cell viability and reactive oxygen species (ROS) level were determined by cell‑counting kit (CCK‑8) assay and flow cytometry, respectively. Alkaline phosphatase (ALP) activity in H2O2‑induced hADMSCs was also detected. The binding condition between miRNA‑429 and SCD‑1 was verified by dual‑luciferase reporter gene assay. Relative levels of osteogenesis‑related genes influenced by SCD‑1 and miRNA‑429 were detected by qRT‑PCR. Furthermore, regulatory effects of SCD‑1 and miRNA‑429 on ALP activity and calcification ability of hADMSCs were evaluated. miRNA‑429 was significantly upregulated in serum of osteoporosis patients. During the process of osteogenesis differentiation, H2O2 induction gradually upregulated miRNA‑429 in hADMSCs. Overexpression of miRNA‑429 markedly reduced ALP activity. Subsequent dual‑luciferase reporter gene assay verified that miRNA‑429 could bind to SCD‑1 and negatively regulated its protein level in hADMSCs. SCD‑1 was obviously downregulated in the osteogenesis differentiation of hADMSCs under oxidative stress. Moreover, silencing of SCD‑1 suppressed expression of osteogenesis‑related gene, ALP activity and calcification ability. Notably, SCD‑1 knockdown partially reversed the regulatory effect of miRNA‑429 on the osteogenic differentiation of hADMSCs. miRNA‑429 suppresses the osteogenic differentiation of hADMSCs under oxidative stress via downregulating SCD‑1.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

View References

1 

Xiang D, He J and Jiang T: The correlation between estrogen receptor gene polymorphism and osteoporosis in Han Chinese women. Eur Rev Med Pharmacol Sci. 22:8084–8090. 2018.PubMed/NCBI

2 

Choi YS, Noh SE, Lim SM, Lee CW, Kim CS, Im MW, Lee MH and Kim DI: Multipotency and growth characteristic of periosteum-derived progenitor cells for chondrogenic, osteogenic, and adipogenic differentiation. Biotechnol Lett. 30:593–601. 2008. View Article : Google Scholar : PubMed/NCBI

3 

De Bari C, Dell'Accio F, Tylzanowski P and Luyten FP: Multipotent mesenchymal stem cells from adult human synovial membrane. Arthritis Rheum. 44:1928–1942. 2001. View Article : Google Scholar : PubMed/NCBI

4 

Dodson MV, Hausman GJ, Guan L, Du M, Rasmussen TP, Poulos SP, Mir P, Bergen WG, Fernyhough ME, McFarland DC, et al: Skeletal muscle stem cells from animals I. Basic cell biology. Int J Biol Sci. 6:465–474. 2010. View Article : Google Scholar : PubMed/NCBI

5 

Feng J, Mantesso A and Sharpe PT: Perivascular cells as mesenchymal stem cells. Expert Opin Biol Ther. 10:1441–1451. 2010. View Article : Google Scholar : PubMed/NCBI

6 

Shi M, Ishikawa M, Kamei N, Nakasa T, Adachi N, Deie M, Asahara T and Ochi M: Acceleration of skeletal muscle regeneration in a rat skeletal muscle injury model by local injection of human peripheral blood-derived CD133-positive cells. Stem Cells. 27:949–960. 2009. View Article : Google Scholar : PubMed/NCBI

7 

Baksh D, Yao R and Tuan RS: Comparison of proliferative and multilineage differentiation potential of human mesenchymal stem cells derived from umbilical cord and bone marrow. Stem Cells. 25:1384–1392. 2007. View Article : Google Scholar : PubMed/NCBI

8 

Musina RA, Bekchanova ES and Sukhikh GT: Comparison of mesenchymal stem cells obtained from different human tissues. Bull Exp Biol Med. 139:504–509. 2005. View Article : Google Scholar : PubMed/NCBI

9 

Cyranoski D: Stem cells boom in vet clinics. Nature. 496:148–149. 2013. View Article : Google Scholar : PubMed/NCBI

10 

An C, Cheng Y, Yuan Q and Li J: IGF-1 and BMP-2 induces differentiation of adipose-derived mesenchymal stem cells into chondrocytes-like cells. Ann Biomed Eng. 38:1647–1654. 2010. View Article : Google Scholar : PubMed/NCBI

11 

Zhang W, Schmull S, Du M, Liu J, Lu Z, Zhu H, Xue S and Lian F: Estrogen receptor α and β in mouse: Adipose-derived stem cell proliferation, migration, and brown adipogenesis in vitro. Cell Physiol Biochem. 38:2285–2299. 2016. View Article : Google Scholar : PubMed/NCBI

12 

Wei Y, Fang J, Cai S, Lv C, Zhang S and Hua J: Primordial germ cell-like cells derived from canine adipose mesenchymal stem cells. Cell Prolif. 49:503–511. 2016. View Article : Google Scholar : PubMed/NCBI

13 

Parvizi M, Bolhuis-Versteeg LA, Poot AA and Harmsen MC: Efficient generation of smooth muscle cells from adipose-derived stromal cells by 3D mechanical stimulation can substitute the use of growth factors in vascular tissue engineering. Biotechnol J. 11:932–944. 2016. View Article : Google Scholar : PubMed/NCBI

14 

Lewis BP, Burge CB and Bartel DP: Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell. 120:15–20. 2005. View Article : Google Scholar : PubMed/NCBI

15 

Bae Y, Yang T, Zeng HC, Campeau PM, Chen Y, Bertin T, Dawson BC, Munivez E, Tao J and Lee BH: miRNA-34c regulates Notch signaling during bone development. Hum Mol Genet. 21:2991–3000. 2012. View Article : Google Scholar : PubMed/NCBI

16 

Wei J, Shi Y, Zheng L, Zhou B, Inose H, Wang J, Guo XE, Grosschedl R and Karsenty G: miR-34s inhibit osteoblast proliferation and differentiation in the mouse by targeting SATB2. J Cell Biol. 197:509–521. 2012. View Article : Google Scholar : PubMed/NCBI

17 

Du F, Wu H, Zhou Z and Liu YU: microRNA-375 inhibits osteogenic differentiation by targeting runt-related transcription factor 2. Exp Ther Med. 10:207–212. 2015. View Article : Google Scholar : PubMed/NCBI

18 

Fu S, Zhang J and Zhang S: Knockdown of miR-429 attenuates Aβ-induced neuronal damage by targeting SOX2 and BCL2 in mouse cortical neurons. Neurochem Res. 43:2240–2251. 2018. View Article : Google Scholar : PubMed/NCBI

19 

Ntambi JM and Miyazaki M: Regulation of stearoyl-CoA desaturases and role in metabolism. Prog Lipid Res. 43:91–104. 2004. View Article : Google Scholar : PubMed/NCBI

20 

Cohen P, Ntambi JM and Friedman JM: Stearoyl-CoA desaturase-1 and the metabolic syndrome. Curr Drug Targets Immune Endocr Metabol Disord. 3:271–280. 2003. View Article : Google Scholar : PubMed/NCBI

21 

Tao J, Shi J, Lu Y, Dou B, Zhou Z, Gao M and Zhu Z: Overexpression of stearoyl-CoA desaturase 1 in bone-marrow mesenchymal stem cells increases osteogenesis. Panminerva Med. 55:283–289. 2013.PubMed/NCBI

22 

Tang Y, Vater C, Jacobi A, Liebers C, Zou X and Stiehler M: Salidroside exerts angiogenic and cytoprotective effects on human bone marrow-derived endothelial progenitor cells via Akt/mTOR/p70S6K and MAPK signalling pathways. Br J Pharmacol. 171:2440–2456. 2014. View Article : Google Scholar : PubMed/NCBI

23 

Ebert MS and Sharp PA: Roles for microRNAs in conferring robustness to biological processes. Cell. 149:515–524. 2012. View Article : Google Scholar : PubMed/NCBI

24 

Li Z, Hassan MQ, Volinia S, van Wijnen AJ, Stein JL, Croce CM, Lian JB and Stein GS: A microRNA signature for a BMP2-induced osteoblast lineage commitment program. Proc Natl Acad Sci USA. 105:13906–13911. 2008. View Article : Google Scholar : PubMed/NCBI

25 

Hassan MQ, Gordon JA, Beloti MM, Croce CM, van Wijnen AJ, Stein JL, Stein GS and Lian JB: A network connecting Runx2, SATB2, and the miR-23a~27a~24-2 cluster regulates the osteoblast differentiation program. Proc Natl Acad Sci USA. 107:19879–19884. 2010. View Article : Google Scholar : PubMed/NCBI

26 

Kapinas K, Kessler C, Ricks T, Gronowicz G and Delany AM: miR-29 modulates Wnt signaling in human osteoblasts through a positive feedback loop. J Biol Chem. 285:25221–25231. 2010. View Article : Google Scholar : PubMed/NCBI

27 

Mizuno Y, Yagi K, Tokuzawa Y, Kanesaki-Yatsuka Y, Suda T, Katagiri T, Fukuda T, Maruyama M, Okuda A, Amemiya T, et al: miR-125b inhibits osteoblastic differentiation by downregulation of cell proliferation. Biochem Biophys Res Commun. 368:267–272. 2008. View Article : Google Scholar : PubMed/NCBI

28 

Inose H, Ochi H, Kimura A, Fujita K, Xu R, Sato S, Iwasaki M, Sunamura S, Takeuchi Y, Fukumoto S, et al: A microRNA regulatory mechanism of osteoblast differentiation. Proc Natl Acad Sci USA. 106:20794–20799. 2009. View Article : Google Scholar : PubMed/NCBI

29 

Zhang Y, Xie RL, Croce CM, Stein JL, Lian JB, van Wijnen AJ and Stein GS: A program of microRNAs controls osteogenic lineage progression by targeting transcription factor Runx2. Proc Natl Acad Sci USA. 108:9863–9868. 2011. View Article : Google Scholar : PubMed/NCBI

30 

Xue H and Tian GY: miR-429 regulates the metastasis and EMT of HCC cells through targeting RAB23. Arch Biochem Biophys. 637:48–55. 2018. View Article : Google Scholar : PubMed/NCBI

31 

Sheng N, Zhang L and Yang S: MicroRNA-429 decreases the invasion ability of gastric cancer cell line BGC-823 by downregulating the expression of heparanase. Exp Ther Med. 15:1927–1933. 2018.PubMed/NCBI

32 

Li J, Du L, Yang Y, Wang C, Liu H, Wang L, Zhang X, Li W, Zheng G and Dong Z: miR-429 is an independent prognostic factor in colorectal cancer and exerts its anti-apoptotic function by targeting SOX2. Cancer Lett. 329:84–90. 2013. View Article : Google Scholar : PubMed/NCBI

33 

Nojiri H, Saita Y, Morikawa D, Kobayashi K, Tsuda C, Miyazaki T, Saito M, Marumo K, Yonezawa I, Kaneko K, et al: Cytoplasmic superoxide causes bone fragility owing to low-turnover osteoporosis and impaired collagen cross-linking. J Bone Miner Res. 26:2682–2694. 2011. View Article : Google Scholar : PubMed/NCBI

34 

Almeida M, Han L, Martin-Millan M, Plotkin LI, Stewart SA, Roberson PK, Kousteni S, O'Brien CA, Bellido T, Parfitt AM, et al: Skeletal involution by age-associated oxidative stress and its acceleration by loss of sex steroids. J Biol Chem. 282:27285–27297. 2007. View Article : Google Scholar : PubMed/NCBI

35 

Bai XC, Lu D, Bai J, Zheng H, Ke ZY, Li XM and Luo SQ: Oxidative stress inhibits osteoblastic differentiation of bone cells by ERK and NF-kappaB. Biochem Biophys Res Commun. 314:197–207. 2004. View Article : Google Scholar : PubMed/NCBI

36 

Manolagas SC: From estrogen-centric to aging and oxidative stress: A revised perspective of the pathogenesis of osteoporosis. Endocr Rev. 31:266–300. 2010. View Article : Google Scholar : PubMed/NCBI

37 

Nile AH and Hannoush RN: Fatty acylation of Wnt proteins. Nat Chem Biol. 12:60–69. 2016. View Article : Google Scholar : PubMed/NCBI

38 

Rios-Esteves J and Resh MD: Stearoyl CoA desaturase is required to produce active, lipid-modified Wnt proteins. Cell Rep. 4:1072–1081. 2013. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Lan C, Long L, Xie K, Liu J, Zhou L, Pan S, Liang J, Tu Z, Gao Z, Tang Y, Tang Y, et al: miRNA‑429 suppresses osteogenic differentiation of human adipose‑derived mesenchymal stem cells under oxidative stress via targeting SCD‑1 Retraction in /10.3892/etm.2022.11311. Exp Ther Med 19: 696-702, 2020.
APA
Lan, C., Long, L., Xie, K., Liu, J., Zhou, L., Pan, S. ... Tang, Y. (2020). miRNA‑429 suppresses osteogenic differentiation of human adipose‑derived mesenchymal stem cells under oxidative stress via targeting SCD‑1 Retraction in /10.3892/etm.2022.11311. Experimental and Therapeutic Medicine, 19, 696-702. https://doi.org/10.3892/etm.2019.8246
MLA
Lan, C., Long, L., Xie, K., Liu, J., Zhou, L., Pan, S., Liang, J., Tu, Z., Gao, Z., Tang, Y."miRNA‑429 suppresses osteogenic differentiation of human adipose‑derived mesenchymal stem cells under oxidative stress via targeting SCD‑1 Retraction in /10.3892/etm.2022.11311". Experimental and Therapeutic Medicine 19.1 (2020): 696-702.
Chicago
Lan, C., Long, L., Xie, K., Liu, J., Zhou, L., Pan, S., Liang, J., Tu, Z., Gao, Z., Tang, Y."miRNA‑429 suppresses osteogenic differentiation of human adipose‑derived mesenchymal stem cells under oxidative stress via targeting SCD‑1 Retraction in /10.3892/etm.2022.11311". Experimental and Therapeutic Medicine 19, no. 1 (2020): 696-702. https://doi.org/10.3892/etm.2019.8246
Copy and paste a formatted citation
x
Spandidos Publications style
Lan C, Long L, Xie K, Liu J, Zhou L, Pan S, Liang J, Tu Z, Gao Z, Tang Y, Tang Y, et al: miRNA‑429 suppresses osteogenic differentiation of human adipose‑derived mesenchymal stem cells under oxidative stress via targeting SCD‑1 Retraction in /10.3892/etm.2022.11311. Exp Ther Med 19: 696-702, 2020.
APA
Lan, C., Long, L., Xie, K., Liu, J., Zhou, L., Pan, S. ... Tang, Y. (2020). miRNA‑429 suppresses osteogenic differentiation of human adipose‑derived mesenchymal stem cells under oxidative stress via targeting SCD‑1 Retraction in /10.3892/etm.2022.11311. Experimental and Therapeutic Medicine, 19, 696-702. https://doi.org/10.3892/etm.2019.8246
MLA
Lan, C., Long, L., Xie, K., Liu, J., Zhou, L., Pan, S., Liang, J., Tu, Z., Gao, Z., Tang, Y."miRNA‑429 suppresses osteogenic differentiation of human adipose‑derived mesenchymal stem cells under oxidative stress via targeting SCD‑1 Retraction in /10.3892/etm.2022.11311". Experimental and Therapeutic Medicine 19.1 (2020): 696-702.
Chicago
Lan, C., Long, L., Xie, K., Liu, J., Zhou, L., Pan, S., Liang, J., Tu, Z., Gao, Z., Tang, Y."miRNA‑429 suppresses osteogenic differentiation of human adipose‑derived mesenchymal stem cells under oxidative stress via targeting SCD‑1 Retraction in /10.3892/etm.2022.11311". Experimental and Therapeutic Medicine 19, no. 1 (2020): 696-702. https://doi.org/10.3892/etm.2019.8246
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team